Lv21
150 积分 2022-10-24 加入
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
10小时前
已完结
Targeted therapy in acute myeloid leukemia: resistance and overcoming strategy
7天前
已完结
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
13天前
已完结
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
15天前
已完结
Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120
29天前
已完结
Comparison of Gastrointestinal pH in Dogs and Humans: Implications on the Use of the Beagle Dog as a Model for Oral Absorption in Humans
1个月前
已完结
Epidemiology of biliary tract cancer in China: A narrative review
1个月前
已完结
Phase I study of the mutant IDH1 inhibitor ivosidenib: long-term safety and clinical activity in patients with conventional chondrosarcoma
2个月前
已完结
The Clinical Management of Chondrosarcoma
2个月前
已完结
The Clinical Approach Towards Chondrosarcoma
2个月前
已完结
皖公网安备34019202002308
